140 related articles for article (PubMed ID: 23342254)
21. Universal human papillomavirus genotyping by the digene HPV Genotyping RH and LQ Tests.
Geraets DT; Lenselink CH; Bekkers RL; van Doorn LJ; Quint WG; Melchers WJ
J Clin Virol; 2011 Apr; 50(4):276-80. PubMed ID: 21296612
[TBL] [Abstract][Full Text] [Related]
22. Screening for cervical cancer: new alternatives and research.
Lörincz AT
Salud Publica Mex; 2003; 45 Suppl 3():S376-87. PubMed ID: 14746031
[TBL] [Abstract][Full Text] [Related]
23. Comparison of the PANArray HPV Genotyping Chip Test with the Cobas 4800 HPV and Hybrid Capture 2 Tests for Detection of HPV in ASCUS Women.
Ki EY; Lee YK; Lee A; Park JS
Yonsei Med J; 2018 Jul; 59(5):662-668. PubMed ID: 29869464
[TBL] [Abstract][Full Text] [Related]
24. Targeted next generation sequencing panel for HPV genotyping in cervical cancer.
Lippert J; Bønløkke S; Utke A; Knudsen BR; Sorensen BS; Steiniche T; Stougaard M
Exp Mol Pathol; 2021 Feb; 118():104568. PubMed ID: 33171155
[TBL] [Abstract][Full Text] [Related]
25. Comparison of Four Human Papillomavirus Genotyping Methods: Next-generation Sequencing, INNO-LiPA, Electrochemical DNA Chip, and Nested-PCR.
Nilyanimit P; Chansaenroj J; Poomipak W; Praianantathavorn K; Payungporn S; Poovorawan Y
Ann Lab Med; 2018 Mar; 38(2):139-146. PubMed ID: 29214758
[TBL] [Abstract][Full Text] [Related]
26. Retrospective and prospective evaluation of the Amplicor HPV test for detection of 13 high-risk human papillomavirus genotypes on 862 clinical samples.
Poljak M; Fujs K; Seme K; Kocjan BJ; Vrtacnik-Bokal E
Acta Dermatovenerol Alp Pannonica Adriat; 2005 Dec; 14(4):147-52. PubMed ID: 16435043
[TBL] [Abstract][Full Text] [Related]
27. Detection of human papillomavirus DNA in routine cervical scraping samples: use for a national cervical cancer screening program in a developing nation.
Othman N; Othman NH
Asian Pac J Cancer Prev; 2014; 15(5):2245-9. PubMed ID: 24716964
[TBL] [Abstract][Full Text] [Related]
28. Evaluation of the Clinical Performance of the HPV-Risk Assay Using the VALGENT-3 Panel.
Polman NJ; Oštrbenk A; Xu L; Snijders PJF; Meijer CJLM; Poljak M; Heideman DAM; Arbyn M
J Clin Microbiol; 2017 Dec; 55(12):3544-3551. PubMed ID: 29021152
[TBL] [Abstract][Full Text] [Related]
29. Human papillomavirus genotype specificity of hybrid capture 2.
Castle PE; Solomon D; Wheeler CM; Gravitt PE; Wacholder S; Schiffman M
J Clin Microbiol; 2008 Aug; 46(8):2595-604. PubMed ID: 18579716
[TBL] [Abstract][Full Text] [Related]
30. Comparison of the analytical and clinical performances of Abbott RealTime High Risk HPV, Hybrid Capture 2, and DNA Chip assays in gynecology patients.
Park S; Kang Y; Kim DG; Kim EC; Park SS; Seong MW
Diagn Microbiol Infect Dis; 2013 Aug; 76(4):432-6. PubMed ID: 23791386
[TBL] [Abstract][Full Text] [Related]
31. Establishment and Application of a Method for High-Risk Human Papillomavirus Genotyping in Cervical Cancer Tissue.
Zou R; Xie W; Wang H; Wang J; Xiao L; Ji S; Chen X; Zhang L; Xue X; Chen J
Clin Lab; 2016; 62(6):1075-85. PubMed ID: 27468570
[TBL] [Abstract][Full Text] [Related]
32. Comparison between direct sequencing and INNO-LiPA methods for HPV detection and genotyping in Thai Women.
Chinchai T; Chansaenroj J; Junyangdikul P; Swangvaree S; Karalak A; Niruthisard S; Poovorawan Y
Asian Pac J Cancer Prev; 2011; 12(4):989-94. PubMed ID: 21790239
[TBL] [Abstract][Full Text] [Related]
33. Diagnostic accuracy of high-risk HPV genotyping in women with high-grade cervical lesions: evidence for improving the cervical cancer screening strategy in China.
Xu H; Lin A; Shao X; Shi W; Zhang Y; Yan W
Oncotarget; 2016 Dec; 7(50):83775-83783. PubMed ID: 27626178
[TBL] [Abstract][Full Text] [Related]
34. The Abbott RealTime High Risk HPV test is a clinically validated human papillomavirus assay for triage in the referral population and use in primary cervical cancer screening in women 30 years and older: a review of validation studies.
Poljak M; Oštrbenk A
Acta Dermatovenerol Alp Pannonica Adriat; 2013; 22(2):43-7. PubMed ID: 23836358
[TBL] [Abstract][Full Text] [Related]
35. Detection and genotyping of human papillomavirus by five assays according to cytologic results.
Choi J; Park Y; Lee EH; Kim S; Kim JH; Kim HS
J Virol Methods; 2013 Jan; 187(1):79-84. PubMed ID: 22982075
[TBL] [Abstract][Full Text] [Related]
36. Molecular tests for human papillomavirus (HPV), Chlamydia trachomatis and Neisseria gonorrhoeae in liquid-based cytology specimen.
Lee SH; Vigliotti VS; Pappu S
BMC Womens Health; 2009 Apr; 9():8. PubMed ID: 19358733
[TBL] [Abstract][Full Text] [Related]
37. Comparison of initial stream urine samples and cervical samples for detection of human papillomavirus.
Hagihara M; Yamagishi Y; Izumi K; Miyazaki N; Suzuki T; Kato H; Nishiyama N; Koizumi Y; Suematsu H; Mikamo H
J Infect Chemother; 2016 Aug; 22(8):559-62. PubMed ID: 27342077
[TBL] [Abstract][Full Text] [Related]
38. Human papillomavirus detection: verification with cervical cytology.
Matthews-Greer J; Rivette D; Reyes R; Vanderloos CF; Turbat-Herrera EA
Clin Lab Sci; 2004; 17(1):8-11. PubMed ID: 15011974
[TBL] [Abstract][Full Text] [Related]
39. Assessment of the Roche Linear Array HPV Genotyping Test within the VALGENT framework.
Xu L; Oštrbenk A; Poljak M; Arbyn M
J Clin Virol; 2018 Jan; 98():37-42. PubMed ID: 29241150
[TBL] [Abstract][Full Text] [Related]
40. Comparison of the clinical performance of restriction fragment mass polymorphism (RFMP) and Roche linear array HPV test assays for HPV detection and genotyping.
Lee HP; Cho W; Bae JM; Shin JY; Shin SK; Hwang SY; Min KT; Kim SN; Lee SJ; Kim SO; Yoo WD; Hong SP
J Clin Virol; 2013 Jun; 57(2):130-5. PubMed ID: 23410688
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]